{"database": "open_comments", "table": "documents", "rows": [["FDA-2026-N-3273-0001", "FDA", "FDA-2026-N-3273", "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-15", 2026, 4, "2026-04-15", "2026-07-24", "2026-04-15 17:05:22", "2026-07248", 1, 0, "09000064b9282224"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-3273-0001"], "units": {}, "query_ms": 1.4502659905701876, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}